These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16508533)

  • 1. Physiotherapy assessment and treatment for an ambulant child with cerebral palsy after botox A to the lower limbs: a case report.
    Mulligan H; Wilmshurst E
    Pediatr Phys Ther; 2006; 18(1):39-48. PubMed ID: 16508533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Botulinum toxin treatment of hip adductor spasticity in multiple sclerosis].
    Wissel J; Entner T
    Wien Klin Wochenschr; 2001; 113 Suppl 4():20-4. PubMed ID: 15506048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
    Kaishou Xu ; Tiebin Yan ; Jianning Mai
    Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of botulinum toxin (A) in the management of calf spasticity in children with diplegic cerebral palsy.
    Hawamdeh ZM; Ibrahim AI; Al-Qudah AA
    Eura Medicophys; 2007 Sep; 43(3):311-8. PubMed ID: 17268388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a multimodal management of prematurity-related spasticity.
    Papavasiliou AS; Rapidi CA; Filiopoulos C; Rizou C; Skouteli HN
    Pediatr Neurol; 2006 Dec; 35(6):400-7. PubMed ID: 17138009
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin-a in children with congenital spastic hemiplegia does not improve upper extremity motor-related function over rehabilitation alone: a randomized controlled trial.
    Rameckers EA; Speth LA; Duysens J; Vles JS; Smits-Engelsman BC
    Neurorehabil Neural Repair; 2009; 23(3):218-25. PubMed ID: 19106252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Botulinum toxin (Dysport) treatment of the spastic gastrocnemius muscle in children with cerebral palsy: a randomized trial comparing two injection volumes.
    Hu GC; Chuang YC; Liu JP; Chien KL; Chen YM; Chen YF
    Clin Rehabil; 2009 Jan; 23(1):64-71. PubMed ID: 19114438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of spasticity in cerebral palsy with botulinum toxin].
    Calderón-González R; Calderón-Sepúlveda RF
    Rev Neurol; 2002 Jan 1-15; 34(1):52-9. PubMed ID: 11988892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospective study examining remote effects of botulinum toxin a in children with cerebral palsy.
    Crowner BE; Racette BA
    Pediatr Neurol; 2008 Oct; 39(4):253-8. PubMed ID: 18805363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term effects of botulinum toxin A in children with cerebral palsy.
    Tedroff K; Granath F; Forssberg H; Haglund-Akerlind Y
    Dev Med Child Neurol; 2009 Feb; 51(2):120-7. PubMed ID: 19191845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional outcomes of intramuscular botulinum toxin type a and occupational therapy in the upper limbs of children with cerebral palsy: a randomized controlled trial.
    Wallen M; O'Flaherty SJ; Waugh MC
    Arch Phys Med Rehabil; 2007 Jan; 88(1):1-10. PubMed ID: 17207668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Botulinum toxin type A in the treatment plan for cerebral palsy].
    Strobl W
    Wien Klin Wochenschr; 2001; 113 Suppl 4():30-5. PubMed ID: 15506050
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effectiveness of botulinum toxin injections in the lower limb muscles of children with cerebral palsy. Preliminary prospective study of the advantages of ultrasound guidance.
    Py AG; Zein Addeen G; Perrier Y; Carlier RY; Picard A
    Ann Phys Rehabil Med; 2009 Apr; 52(3):215-23. PubMed ID: 19447084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
    Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
    Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
    Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
    Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of botulinum toxin a in the management of lower limb spasticity in patients with cerebral palsy.
    Dursun N; Dursun E; Alican D
    Int J Clin Pract; 2002 Oct; 56(8):564-7. PubMed ID: 12425363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin type A injections can be an effective treatment for pain in children with hip spasms and cerebral palsy.
    Lundy CT; Doherty GM; Fairhurst CB
    Dev Med Child Neurol; 2009 Sep; 51(9):705-10. PubMed ID: 19459910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term efficacy and tolerability of 4-monthly versus yearly botulinum toxin type A treatment for lower-limb spasticity in children with cerebral palsy.
    Kanovský P; Bares M; Severa S; Richardson A;
    Dev Med Child Neurol; 2009 Jun; 51(6):436-45. PubMed ID: 19563586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Botulinum toxin A in the management of focal muscle overactivity in children with cerebral palsy.
    Gibson N; Graham HK; Love S
    Disabil Rehabil; 2007 Dec; 29(23):1813-22. PubMed ID: 18033606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Upper limb function after botulinum toxin A treatment in cerebral palsy: two years follow-up of six cases.
    Sätilä H; Kotamäki A; Koivikko M; Autti-Rämö I
    Pediatr Rehabil; 2006; 9(3):247-58. PubMed ID: 17050402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.